Please provide your email address to receive an email when new articles are posted on . Pekle and colleagues conducted a retrospective analysis of a phase 3 study that determined the efficacy and ...

Learn everything you need to know about Granisetron-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule. In a double-blind, randomized, stratified, parallel-group study, the efficacy and safety of granisetron and ...

Background: Women undergoing general anaesthesia for breast surgery are especially at risk of experiencing postoperative nausea and vomiting (PONV). This study was undertaken to assess the efficacy of ...

Active ingredient: Granisetron 3.1 mg/24 hours; transdermal delivery system (patch). Indication: Prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic ...

Of the 327 patient records screened, 224 met the study's inclusion criteria. Sixty-eight patients (30%) received prophylactic ondansetron 8 mg as antiemetic therapy in conjunction with chemotherapy ...

Review the side-effects of Granisetron as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Granisetron (as HCl) 1mg/mL (contains benzyl alcohol); 0.1mg/mL (preservative-free); IV inj. Chemotherapy: give as an undiluted IV injection over 30 seconds or as a diluted IV infusion over 5 minutes.

CALIFON, N.J., April 13, 2011 /PRNewswire/ -- PediatRx, Inc. (OTCBB: PEDX) announced that the U.S. Centers for Medicare and Medicaid Services (CMS) recently notified state Medicaid agencies to include ...